Ultromics Company
They are building world-class diagnostic aids to help cardiologists вАФ powered by artificial intelligence. To date, they have developed the worldвАЩs most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.
Investors
%20.png)
Total Funding:
58824943
Headquarters:
Oxford, Oxfordshire, United Kingdom
Funding Status:
Early Stage Venture
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Technology:
HealthCare Administration
Last Funding Date:
2021-08-16
Investors Number:
13
Founded Date:
2017-01-01
Industry:
Imaging